SLXN

Silexion Therapeutics Corp - Ordinary Shares (SLXN)

About Silexion Therapeutics Corp - Ordinary Shares (SLXN)

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.

Details

Daily high

$2.69

Daily low

$2.51

Price at open

$2.63

52 Week High

$51.75

52 Week Low

$2.13

Market cap

8.2M

Dividend yield

0.00%

Volume

38,322

Avg. volume

59,738

P/E ratio

-.10

Silexion Therapeutics Corp - Ordinary Shares News